THE NEXT LOTTO and UNDER THE RADAR PICKS

[Bernstein]

ETON=First FDA Decision TOMORROW for a Drug targeting $600+ MILLION Market / Second FDA Decision in October =$$$$$$:

(ETON) ..Market Cap $130 M / 3x FDA decisions soon : on July 11 , October 21 & May 2020 / 3x NDA expected to be submitted to FDA in second half of 2019 / has HUGE late stage pipeline with multiple near-term milestones / undiscovered Ultra low float stock = A Potential 1000% GEM and attractive takeover target ..

"EM-100. EM-100, Eton’s preservative-free ophthalmic solution for allergic conjunctivitis has been assigned a target action date of July 11, 2019. Bausch Health will be responsible for all remaining regulatory and commercial activities surrounding the product. Eton is entitled to a milestone payment upon product launch and a royalty on commercial sales."

•Diversified pipeline of 11 products under development. Four products submitted to the FDA,three additional NDA’s expected to be submitted in 2019

•Expect to become commercial revenue company in 2019